rdf:type |
|
lifeskim:mentions |
umls-concept:C0013879,
umls-concept:C0027410,
umls-concept:C0034801,
umls-concept:C0064239,
umls-concept:C0068389,
umls-concept:C0185023,
umls-concept:C0205314,
umls-concept:C0231491,
umls-concept:C0237497,
umls-concept:C0243072,
umls-concept:C0392747,
umls-concept:C0439097,
umls-concept:C0456387,
umls-concept:C0679622,
umls-concept:C1314972,
umls-concept:C1442065,
umls-concept:C1547348,
umls-concept:C1611588,
umls-concept:C1705241,
umls-concept:C1947904,
umls-concept:C1999228,
umls-concept:C2825781,
umls-concept:C2936235
|
pubmed:issue |
1
|
pubmed:dateCreated |
1993-2-16
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Morphinans,
http://linkedlifedata.com/resource/pubmed/chemical/Naltrexone,
http://linkedlifedata.com/resource/pubmed/chemical/Narcotic Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, delta,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, kappa,
http://linkedlifedata.com/resource/pubmed/chemical/naltrindole
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-2623
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
179-80
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8380614-Animals,
pubmed-meshheading:8380614-Guinea Pigs,
pubmed-meshheading:8380614-Indoles,
pubmed-meshheading:8380614-Morphinans,
pubmed-meshheading:8380614-Naltrexone,
pubmed-meshheading:8380614-Narcotic Antagonists,
pubmed-meshheading:8380614-Receptors, Opioid, delta,
pubmed-meshheading:8380614-Receptors, Opioid, kappa,
pubmed-meshheading:8380614-Structure-Activity Relationship
|
pubmed:year |
1993
|
pubmed:articleTitle |
A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic kappa address element to the delta antagonist, natrindole: 5'-[N2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists.
|
pubmed:affiliation |
Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis 55455.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|